Dietary Supplements

(WASHINGTON, D.C.) – Consumer Healthcare Products Association (CHPA) Vice President of State & Local Government Affairs Carlos Gutiérrez today released the below statement following West Virginia’s passing and signing legislation that will prohibit the sale of dietary supplements containing certain additives.

CHPA President and CEO Scott Melville released a statement today following the U.S. Senate confirming the nomination of Dr. Martin Makary to serve as the next Commissioner of the U.S. Food and Drug Administration (FDA) by a recorded vote of 56-44.

“CHPA and its member companies look forward to working with Secretary Kennedy to advance policies that will enhance American consumers’ access to safe, effective, and affordable self-care options. With a growing demand for OTC medicines, dietary supplements, and OTC medical devices, it is imperative that our nation’s healthcare leaders expand access, streamline regulatory pathways, and reinforce public confidence through transparent, data-driven decisions. This can be achieved through the reauthorization of the Over-the-Counter Monograph Drug User Fee Program (OMUFA), Rx-to-OTC switch improvements, and the modernization of the more than 30-year-old Dietary Supplement Health and Education Act (DSHEA).

The Consumer Healthcare Products Association (CHPA) today announced the recent hiring of Dr. Fred Meadows as its new Senior Director of Quality, Technical, and Regulatory Affairs and Dr. Caitlin Ondracek as its new Senior Director of Medical Science and Regulatory Affairs. Meadows will report to Dr. Marcia Howard, Vice President of Regulatory and Scientific Affairs, and Ondracek will report to Dr. Jay Sirois, Vice President of Regulatory and Scientific Affairs.

Fearing links to human health problems and harm to the environment, state lawmakers are increasingly seeking to restrict the use and/or presence of PFAS in consumer products and packaging, whether intentionally added or not.

As more and more consumers turn to dietary supplements to fill nutrition gaps and support general health and wellness, a growing number of state governments are seeking to regulate these products to ensure the health and safety of constituents who may be consuming them. One area of interest to policymakers in recent years is the category of weight loss products.

OTC medical devices like bandages, menstrual products, face masks, and at-home test kits, used for the purposes of prevention, testing, and treatment are well-accepted, cost saving elements of the healthcare system. Unfortunately, most states that have a retail sales tax, include a tax on the sale of some or all OTC healthcare products. More than 40 states, on the other hand, exempt sales tax of prescription drugs.